Adebayo Alonge
Adebayo Alonge is a Nigerian pharmacist, inventor, deep tech entrepreneur, and market development professional. He emerged as the winner of the 2019 Hello Tomorrow Global deeptech Challenge otherwise known as, BNP Paribas Group Deep Tech Award, for creating a handheld nanoscanner that detects counterfeit drugs. He is the first African to win the contest. He is the CEO and co-founder of RxAll Inc. – a U.S based deep tech Start-up firm.
key person
Link from a Wikipage to another Wikipage
primaryTopic
Adebayo Alonge
Adebayo Alonge is a Nigerian pharmacist, inventor, deep tech entrepreneur, and market development professional. He emerged as the winner of the 2019 Hello Tomorrow Global deeptech Challenge otherwise known as, BNP Paribas Group Deep Tech Award, for creating a handheld nanoscanner that detects counterfeit drugs. He is the first African to win the contest. He is the CEO and co-founder of RxAll Inc. – a U.S based deep tech Start-up firm.
has abstract
Adebayo Alonge is a Nigerian p ...... based deep tech Start-up firm.
@en
alias
Samuel
@en
alma mater
award
nationality
state of origin
Link from a Wikipage to an external page
Wikipage page ID
62,877,464
page length (characters) of wiki page
Wikipage revision ID
1,020,180,171
Link from a Wikipage to another Wikipage
alma mater
Graduate School of International Corporate Strategy
@en
John F. Kennedy School of Government
@en
King's College, Lagos
@en
Lagos Business School
@en
University of Ibadan
@en
Yale School of Management
@en
awards
Awards in person from Barack O ...... or Academic Excellence in 2008
@en
caption
Adebayo Alonge, 2019.
@en
honorific prefix
MNIM
@en
known for
invention of RxScanner
@en
name
Adebayo Alonge
@en
nationality
Nigerian
@en
other names
Samuel
@en
wikiPageUsesTemplate
subject
comment
Adebayo Alonge is a Nigerian p ...... based deep tech Start-up firm.
@en
label
Adebayo Alonge
@en
sameAs
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Adebayo Alonge
@en